/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

ORAMED PHARMACEUTICALS INC Share Price Today: Live Updates & Key Insights

ORAMED PHARMACEUTICALS INC share price today is $3.5, up -3.32%. The stock opened at $3.57 against the previous close of $3.61, with an intraday high of $3.62 and low of $3.48.

ORAMED PHARMACEUTICALS INC Share Price Chart

style
pb-0

ORAMED PHARMACEUTICALS INC

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

ORAMED PHARMACEUTICALS INC Share Price Performance

$3.5 -0.0332(-3.32%) ORMP at 23 Mar 2026 02:37 PM Biotechnology
Lowest Today 3.48
Highest Today 3.62
Today’s Open 3.57
Prev. Close 3.61
52 Week High 3.76
52 Week Low 1.70
Day’s Range: Low 3.48 High 3.62
52-Week Range: Low 1.70 High 3.76
1 day return -
1 Week return +0.28
1 month return +5.1
3 month return +17.05
6 month return +41.7
1 year return +52.17
3 year return +63.55
5 year return -66.24
10 year return -

ORAMED PHARMACEUTICALS INC Institutional Holdings

BML Capital Management LLC 7.96

Aquamarine Financial (Cayman) Ltd 4.96

Murchinson Ltd. 3.37

BOOTHBAY FUND MANAGEMENT, LLC 1.54

Marshall Wace Asset Management Ltd 0.65

Rathbone Brothers PLC 0.59

Citadel Advisors Llc 0.49

Dimensional Fund Advisors, Inc. 0.38

Bank of America Corp 0.38

Renaissance Technologies Corp 0.37

Wells Fargo & Co 0.33

BlackRock Inc 0.28

iShares Micro-Cap ETF 0.23

Jane Street Group LLC 0.20

Squarepoint Ops LLC 0.15

HRT FINANCIAL LLC 0.12

RBC Microcap Value I 0.11

Connor Clark & Lunn Inv Mgmt Ltd 0.11

RBF LLC 0.11

Quadrature Capital Limited 0.10

Dimensional US Core Equity 2 ETF 0.09

Susquehanna International Group, LLP 0.07

Fidelity Nasdaq Composite Index 0.06

Geode Capital Management, LLC 0.06

DFA US Core Equity 2 I 0.06

Avantis US Small Cap Equity ETF 0.05

DFA US Small Cap I 0.03

DFA US Vector Equity I 0.03

Dimensional US Small Cap ETF 0.03

Dimensional Global Core Equity USD Acc 0.02

1290 VT Micro Cap K 0.02

DFA US Social Core Equity 2 Portfolio 0.01

Dimensional Global Small Coms USD Acc 0.01

DFA US Core Equity Class F 0.01

Dimensional US Core Equity 1 ETF 0.01

Dimensional World Allc 60/40 GBP Acc 0.01

Dimensional World Equity GBP Acc 0.01

Avantis US Equity ETF 0.01

Victory Extended Market Index 0.01

Dimensional US Equity Market ETF 0.01

ORAMED PHARMACEUTICALS INC Market Status

Strong Buy: 0

Buy: 0

Hold: 1

Sell: 0

Strong Sell: 0

ORAMED PHARMACEUTICALS INC Fundamentals

Market Cap 139.07 M

PB Ratio 0.7059

PE Ratio 3.49

Enterprise Value 9.86 M

Total Assets 155.28 M

Volume 81367

ORAMED PHARMACEUTICALS INC Company Financials

Annual Revenue FY23:1340000 1.3M, FY23:2703000 2.7M, FY22:2703000 2.7M, FY21:2703000 2.7M, FY20:2710000 2.7M

Annual Profit FY23:null 0.0M, FY23:2703000 2.7M, FY22:null 0.0M, FY21:2703000 2.7M, FY20:2620000 2.6M

Annual Net worth FY23:5525000 5.5M, FY23:-37764000 -37.8M, FY22:-36561000 -36.6M, FY21:-22238000 -22.2M, FY20:-11511000 -11.5M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:2000000 2.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:-31000 -0.0M, Q2/2025:-30000 -0.0M, Q1/2025:13000 0.0M, Q3/2024:null 0.0M, Q2/2024:null 0.0M

Quarterly Net worth Q3/2025:48395000 48.4M, Q2/2025:13288000 13.3M, Q1/2025:-7642000 -7.6M, Q3/2024:-19619000 -19.6M, Q2/2024:9212000 9.2M

About ORAMED PHARMACEUTICALS INC & investment objective

Company Information Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19 and other novel coronaviruses. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.

Organisation Biotechnology

Employees 0

Industry Biotechnology

CEO Mr. Nadav Kidron Esq.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow

ORAMED PHARMACEUTICALS INC FAQs

What is the share price of ORAMED PHARMACEUTICALS INC today?

The current share price of ORAMED PHARMACEUTICALS INC is $3.5.

Can I buy ORAMED PHARMACEUTICALS INC shares in India?

Yes, Indian investors can buy ORAMED PHARMACEUTICALS INC shares by opening an international trading and demat account with Motilal Oswal.

How to buy ORAMED PHARMACEUTICALS INC shares in India?

You can easily invest in ORAMED PHARMACEUTICALS INC shares from India by:

Can I buy fractional shares of ORAMED PHARMACEUTICALS INC?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of ORAMED PHARMACEUTICALS INC?

ORAMED PHARMACEUTICALS INC has a market cap of $139.07 M.

In which sector does ORAMED PHARMACEUTICALS INC belong?

ORAMED PHARMACEUTICALS INC operates in the Biotechnology sector.

What documents are required to invest in ORAMED PHARMACEUTICALS INC stocks?

To invest, you typically need:

What is the PE and PB ratio of ORAMED PHARMACEUTICALS INC?

The PE ratio of ORAMED PHARMACEUTICALS INC is 3.49 and the PB ratio is 0.71.